Relmada Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€28.83M - R&D expenses
€31.68M - EBITDA
-€60.51M - D&A
€16.37M - EBIT
-€60.51M - Interest expenses
€0.00 - EBT
-€58.18M - Tax expenses
€0.00 - Net income
-€58.18M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€4.03M - Changes in working capital
€4.27M - Operating cash flow
-€42.84M - Capex
€3.43 - Other investing cash flow
€0.00 - Net investing cash flow
€42.49M - Total cash dividends paid
€0.00 - Issuance of common stock
-€211.71K - Debt repayment
€0.00 - Other financing cash flow
-€287.52K - Net financing cash flow
-€287.52K - Foreign exchange effects
€0.00 - Net change in cash
-€628.84K - Cash at end of period
€1.16M - Free cash flow
-€42.84M
Balance sheet
- Cash and cash equivalents
€1.16M - Cash and short-term investments
€17.69M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€407.23K - Total current assets
€18.10M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€18.85K - Total non-current assets
€18.85K - Total assets
€18.12M - Accounts payable
€1.17M - Short-term debt
€0.00 - Other current liabilities
€3.24M - Total current liabilities
€4.41M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€27.56K - Total non-current liabilities
€27.56K - Total liabilities
€4.43M - Common stock
€28.48K - Retained earnings
-€573.41M - Other equity
€0.00 - Total equity
€13.68M - Total liabilities and shareholders' equity
€18.12M
Company information
- Market capitalization
€17.27M - Employees
17 - Enterprise Value
€24.29M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-425.1% Much worse than peer group: 44.2% - ROA
-
-321.1% Much better than peer group: -528.6% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-248.0% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€3.42M